Category: Regulatory

Pharmaceutical Regulatory Dossier Preparation: Step-by-Step Guide Pharmaceutical regulatory dossier preparation is a process for pharmaceutical companies trying to get approval to sell their products. A organised dossier gives regulatory agencies the details they need to check if a medicine is good, safe and works.

Pharmaceutical Regulatory Affairs: A Complete Guide for Pharma Companies Regulatory Affairs in the pharmaceuticals sector is of great importance as it ensures compliance with legal, safety, quality, and efficacy requirements set by the relevant authorities.

What Is the Drug Approval Lifecycle? The drug approval lifecycle is the structured sequence through which a new drug passes, starting from fundamental scientific discovery through laboratory investigations to approval by relevant authorities.

What Is Regulatory Labeling Change Management? Regulatory labeling change management is the structured process of identifying, assessing, implementing, documenting, and tracking changes to the approved labeling of a pharmaceutical or medical product.

Regulatory Affairs Consultant: Your Partner in Global Regulatory Compliance A Regulatory Affairs Consultant plays a vital role in helping pharmaceutical, biotechnology, medical device, and healthcare companies navigate complex regulatory requirements.

FDA Updates Forms FDA 1571 and FDA 356h: Key Changes FDA has released updated versions of Form FDA 1571 (05/2026) and Form FDA 356h (05/2026) to support PDUFA VII requirements and improve data quality and usability.

What Is Regulatory Submission Planning? Regulatory Submission Planning is a process that allows the pharmaceutical, biotechnology, and medical devices sector to better organize and manage all the activities related to regulatory submissions.

What Is Multi-Region Drug Registration? Multi-Region Drug Registration refers to the process of getting approval from the regulatory body for the marketing of the medical drug in multiple locations.

What Is Lifecycle Regulatory Strategy? The Lifecycle Regulatory Strategy refers to a systematic method of dealing with the regulatory obligations of a given pharmaceutical product as the regulatory needs arise over the product lifecycle.

What Is an Environmental Risk Assessment Report for Molecules? The Environmental Risk Assessment Report for Molecules is a report which is prepared to assess if and how a certain kind of pharmaceutical molecule can affect the environment.